Clinical bottom line for GLP-1 agonists in PCOS Clearly benefits: Women with PCOS and insulin resistance and/or overweight/obesity specifically for improving cycle regularity, reducing hyperandrogenism, supporting sustained weight loss, and reducing long-term cardiometabolic risk
This metabolic-immune crosstalk establishes mucosal tolerance while curbing pathological inflammation (Smith et al., 2013)
Aging Cell 20 , e13328 (2021)
This proves that it can be a good way for weight management over time
Our research went on, where we found that scientists had tested the same combination in animal models, choline + carnitine, plus added caffeine to the mix to see what would happen
You can see where HSAs and FSAs have their differences, but they play from the same rulebook